BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Forsyth K, Fitzpatrick M, Simpson A, Barratt T, Levinsky R. NEUTROPHIL-MEDIATED ENDOTHELIAL INJURY IN HAEMOLYTIC URAEMIC SYNDROME. The Lancet 1989;334:411-4. [DOI: 10.1016/s0140-6736(89)90591-6] [Cited by in Crossref: 87] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Gómez SA, Fernández GC, Camerano G, Dran G, Rosa FA, Barrionuevo P, Isturiz MA, Palermo MS. Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome. Clin Exp Immunol 2005;139:65-73. [PMID: 15606615 DOI: 10.1111/j.1365-2249.2005.02659.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
2 Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 2006;146:76-84. [PMID: 16968401 DOI: 10.1111/j.1365-2249.2006.03155.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
3 Obrig TG, Karpman D. Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 2012;357:105-36. [PMID: 21983749 DOI: 10.1007/82_2011_172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
4 Gottlieb RA, Pinkel D, Meehan MA, Verani RR, Ashkenazi S, Eftekhari F, Moake JL, Portman RJ. Acute renal failure in a female adolescent with leukemia in remission. J Pediatr 1991;119:999-1006. [PMID: 1960627 DOI: 10.1016/s0022-3476(05)83069-0] [Reference Citation Analysis]
5 Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM. Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 1992;6:50-3. [PMID: 1536740 DOI: 10.1007/BF00856833] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
6 Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, Ogata R, Huang T, Nakajima S, Yao J, Paton AW, Paton JC, Kitamura M. Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J Immunol 2009;183:1480-7. [PMID: 19561103 DOI: 10.4049/jimmunol.0900017] [Cited by in Crossref: 176] [Cited by in F6Publishing: 171] [Article Influence: 13.5] [Reference Citation Analysis]
7 Wang H, Paton AW, McColl SR, Paton JC. In Vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin. Infect Immun 2011;79:1671-9. [PMID: 21282417 DOI: 10.1128/IAI.01204-10] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
9 Beattie TJ. Recent developments in the pathogenesis of hemolytic uremic syndrome. Ren Fail 1990;12:3-7. [PMID: 2236721 DOI: 10.3109/08860229009066958] [Reference Citation Analysis]
10 Flagler MJ, Strasser JE, Chalk CL, Weiss AA. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun 2007;75:760-5. [PMID: 17101648 DOI: 10.1128/IAI.01594-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hirahashi J, Hishikawa K, Kaname S, Tsuboi N, Wang Y, Simon DI, Stavrakis G, Shimosawa T, Xiao L, Nagahama Y, Suzuki K, Fujita T, Mayadas TN. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation 2009;120:1255-65. [PMID: 19752320 DOI: 10.1161/CIRCULATIONAHA.109.873695] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
12 Milford DV, Taylor CM. New insights into the haemolytic uraemic syndromes. Arch Dis Child 1990;65:713-5. [PMID: 2201260 DOI: 10.1136/adc.65.7.713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
13 Robson WL. Haemolytic uraemic syndrome. Paediatr Drugs 2000;2:243-52. [PMID: 10946413 DOI: 10.2165/00128072-200002040-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 Parthasarathy U, Martinelli R, Vollmann EH, Best K, Therien AG. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders. Biochem Pharmacol 2022;195:114847. [PMID: 34801526 DOI: 10.1016/j.bcp.2021.114847] [Reference Citation Analysis]
15 Cameron P, Smith SJ, Giembycz MA, Rotondo D, Plevin R. Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release. Br J Pharmacol 2003;140:1320-30. [PMID: 14597601 DOI: 10.1038/sj.bjp.0705560] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
16 Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-79. [PMID: 9665978 DOI: 10.1128/CMR.11.3.450] [Cited by in Crossref: 936] [Cited by in F6Publishing: 357] [Article Influence: 39.0] [Reference Citation Analysis]
17 Đevenica D, Čikeš Čulić V, Vuica A, Markotić A. Biochemical, pathological and oncological relevance of Gb3Cer receptor. Med Oncol 2011;28 Suppl 1:S675-84. [PMID: 21069478 DOI: 10.1007/s12032-010-9732-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Leyva-Illades D, Cherla RP, Lee MS, Tesh VL. Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells. Infect Immun 2012;80:2109-20. [PMID: 22431646 DOI: 10.1128/IAI.06025-11] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
19 Hurley BP, Thorpe CM, Acheson DW. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun 2001;69:6148-55. [PMID: 11553554 DOI: 10.1128/IAI.69.10.6148-6155.2001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
20 Szabady RL, Lokuta MA, Walters KB, Huttenlocher A, Welch RA. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7. PLoS Pathog 2009;5:e1000320. [PMID: 19247439 DOI: 10.1371/journal.ppat.1000320] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
21 Gómez SA, Fernández GC, Vanzulli S, Dran G, Rubel C, Berki T, Isturiz MA, Palermo MS. Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome. Clin Exp Immunol 2003;131:217-24. [PMID: 12562380 DOI: 10.1046/j.1365-2249.2003.02057.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
22 Lee MS, Tesh VL. Roles of Shiga Toxins in Immunopathology. Toxins (Basel) 2019;11:E212. [PMID: 30970547 DOI: 10.3390/toxins11040212] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
23 Dyke MP, Forsyth KD. Decreased plasma fibronectin concentrations in preterm infants with septicaemia. Arch Dis Child 1993;68:557-60. [PMID: 8323355 DOI: 10.1136/adc.68.5_spec_no.557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Friedrich V, Flores R, Muller A, Bi W, Peerschke EI, Sehba FA. Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J Neuroinflammation 2011;8:103. [PMID: 21854561 DOI: 10.1186/1742-2094-8-103] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
25 Harrison LM, van den Hoogen C, van Haaften WC, Tesh VL. Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides. Infect Immun 2005;73:403-12. [PMID: 15618178 DOI: 10.1128/IAI.73.1.403-412.2005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
26 Amran MY, Fujii J, Suzuki SO, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S. Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice. PLoS One 2013;8:e58959. [PMID: 23516588 DOI: 10.1371/journal.pone.0058959] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
27 Talwalkar JA, Ruymann FW, Marcoux P, Farraye FA. Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis. Dig Dis Sci 2002;47:1096-9. [PMID: 12018906 DOI: 10.1023/a:1015098325971] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Landoni VI, Schierloh P, de Campos Nebel M, Fernández GC, Calatayud C, Lapponi MJ, Isturiz MA. Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity. PLoS Pathog 2012;8:e1002632. [PMID: 22479186 DOI: 10.1371/journal.ppat.1002632] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]